Europos Sąjunga -
islandų -
EMA (European Medicines Agency)
gavreto
roche registration gmbh - pralsetinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
Islandija -
islandų -
LYFJASTOFNUN (Icelandic Medicines Agency)
sporanox hart hylki 100 mg
janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg
Islandija -
islandų -
LYFJASTOFNUN (Icelandic Medicines Agency)
clarithromycin alvogen (clarithromycin ratiopharm) filmuhúðuð tafla 500 mg
alvogen ehf. - clarithromycinum inn - filmuhúðuð tafla - 500 mg
Islandija -
islandų -
LYFJASTOFNUN (Icelandic Medicines Agency)
ticagrelor krka filmuhúðuð tafla 90 mg
krka d.d. novo mesto* - ticagrelor - filmuhúðuð tafla - 90 mg